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Emery et al., pp. 183
Have you submitted a DNA sample to a direct-to-consumer
(DTC) company in the hopes of learning more about your
ancestry? If so, chances are that their calculations were
based on your mtDNA haplogroup. Indeed, the combina-
tion of a high level of polymorphisms and low level of re-
combinations has rendered mtDNA a useful tool in the
study of human demographic history. In some cases, the
male and female lineages will track closely together, allow-
ing mtDNA to serve as a convenient proxy for one’s
ancestry. However, as you might quickly realize, your
mtDNA haplogroup reflects only a portion of your com-
plete ancestry picture. Now, Emery et al. formally compare
mtDNA-based ancestry tests with those that consider mul-
tiple markers across the genome. The authors show that
continental ancestry proportions vary widely among indi-
viduals sharing a given mtDNA haplogroup; likewise,
knowledge of continental ancestry proportions often give
rise to incorrect predictions of mtDNA haplogroups.
Thus, for the majority of individuals—across popula-
tions—mtDNA haplogroup membership provides limited
information about continental ancestry. In light of these
results, consumers might want to consider carefully the re-
sults from DTC tests that rely on mtDNA lineage alone for
ancestry estimates.Transcribing Differences in DNA-Repair Diseases
Singh et al., pp. 194
Diseases such as Cockayne syndrome (CS), trichothiodys-
trophy (TTD), and xeroderma pigmentosum (XP) are asso-
ciated with mutations in ERCC3, ERCC2, and GTF2H5,
which encode proteins that form the TFIIH complex, and
these diseases are largely attributed to defects in DNA
repair. These disease-associated genes also have a role in
DNA transcription, but the effect of previously reported
mutations on transcription remains unclear. In this study,
Singh et al. evaluated specific transcriptional differences
caused by mutations in ERCC3, ERCC2 and GTF2H5,
demonstrating that both recruitment of the TFIIH complex
and the subsequent recruitment of nucleotide excision-
repair factors is altered in slightly different ways in mutant
cells. Additionally, both methylation state and chromatin
looping were differentially altered in the mutants, suggest-1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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The Americing that the TFIIH complex might coordinate chromatin
remodeling. These subtle differences between the mutant
cells, and even among cells expressing different alleles in
the same gene, could help to explain some of the pheno-
typic variability observed in CS, TTD, and XP. Future
studies evaluating the allele-phenotype association could
further refine subgroups within these disorders.Complex CNV Consequences
Newman et al., pp. 208
Copy-number variation (CNV) is associated with a number
of phenotypes, including several severe genetic disorders.
To determine the clinical significance of a rare CNV, re-
searchers consider the genes disrupted and positional
effects, but such considerations can be difficult without ac-
curate information about the molecular structure of the
CNV. In this study, Newman et al. closely examined 184
duplicated regions identified by diagnostic chromosomal
microarray (CMA) to resolve the breakpoints by using
next-generation sequencing to clarify themolecular conse-
quences of these duplications. In most cases, the duplica-
tions were tandem and in direct orientation relative to
the original locus. However, in 17% of the cases, the break-
points revealed that the CNVs were more complex rear-
rangements, including triplications, adjacent duplications,
insertional translocations, and a single example of an in-
verted duplication adjacent to a cryptic terminal deletion.
Some of these rearrangements might produce fusion pro-
teins, but determining whether these protein products
are produced will require further study. Many of the
examined breakpoints had signatures consistent with
nonhomologous end-joining or microhomology-mediated
break-induced replication and were identical in both the
child and the parent who carried the same duplication.
These results highlight the difficulty in interpreting the
consequences of duplications identified by CMA and sup-
port the utility of higher-resolution methods and follow-
up studies for accurate interpretation of CNVs.Insight into Singleton-Merton Syndrome
Jang et al., pp. 266; Rutsch et al., pp. 275
The genetic cause of Singleton-Merton syndrome (SMS), a
rare autosomal-dominant disorder characterized by abnor-
malities of bone, blood vessels, and teeth, has remainedy of Human Genetics. All rights reserved.
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elusive. In this issue, two groups uncover locus heterogene-
ity in this disorder and shed light on the biological under-
pinnings of SMS. In a study focusing on individuals with
an apparently atypical form of SMS, Jang et al. identified
mutations in DDX58, which encodes RIG-I, a pattern-
recognition receptor that plays a role in the cellular anti-
viral response. In a complementary study, Rutsch et al.
identified three families harboring an identical missense
change in IFIH1, the gene encoding MDA5, a RIG-I family
member. In both instances, it appears that the mutations
lead to gain-of-function for the receptors. Although activa-
tion of these two arms of the RIG-I pathway is essential for
proper immune function, the overproduction of IFN-g,
which has been linked to inflammatory disease, seems a
likely culprit in this disorder. Additional work will be
required to establish just how receptor dysfunction, cross-
talk within the pathway, and exposure to distinct patho-
gens converge to generate the spectrum of phenotypes
that defines SMS.
PARK2 Associated with Lung Cancer
You et al., pp. 301
Cancer is a genetic disease, and so therapies that target spe-
cific mutations that cause a specific type of cancer can be
the best approach for successful treatment. Of course,
this approach requires that the mutations resulting in dis-180 The American Journal of Human Genetics 96, 179–180, Februaryease are identified and that a therapy can be developed to
counteract the effects of the mutated gene. Lung cancer
has already benefited from targeted therapies, and as addi-
tional variants of large effect are uncovered, the potential
for targeted therapy increases. In this study, You et al.
used whole-exome sequencing and candidate Sanger
sequencing to identify a recurrent germline PARK2 muta-
tion that is associated with lung cancer in four unrelated
families. The mutation segregates with lung cancer in the
affected families, has a large effect size, and is observed at
significantly higher frequency in a cohort of individuals
affected with familial lung cancer than it is in controls.
Interestingly, the same amino acid residue is altered in
somatic lung cancer, in which tumorigeneis appeared to
be a result of cyclin accumulation resulting from the loss
PARK2 E3 ligase activity. Although PARK2 mutations
have been previously reported to be associated with Par-
kinson disease (PD), none of the families in this study re-
ported a history of PD. In the future, the association of
PARK2 mutations with lung cancer in individuals with
PD might help determine whether certain PARK2 muta-
tions lead to a single disease outcome through a specific
mechanism or whether the same general mechanism,
such as proteasome dysfunction, results in both lung can-
cer and PD. If such a pattern is observed, then perhaps a
similar targeted therapy for PARK2 mutations could be
applied in both disease states.5, 2015
